MedTrace Logo

Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation

NCT00120432 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-03-09

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy on pupillary dilation between the single dose versus the three doses of 1% tropicamide with 10% phenylephrine for complete ocular examination.

Conditions

  • Eye Diseases

Interventions

DRUG

1% tropicamide and 10% phenylephrine

single dose vs three doses of 1%tropicamide and 10%phenylephrine

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Yosanan Yospaiboon, M.D. · Faculty of Medicine, Khon Kaen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Completion
2005-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00120432 on ClinicalTrials.gov